Xponance Inc. Acquires 122 Shares of Integer Holdings Corporation (NYSE:ITGR)

Xponance Inc. lifted its position in Integer Holdings Corporation (NYSE:ITGR) by 5.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,518 shares of the medical equipment provider’s stock after purchasing an additional 122 shares during the period. Xponance Inc.’s holdings in Integer were worth $297,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Integer in the fourth quarter worth $208,000. Teacher Retirement System of Texas purchased a new stake in shares of Integer in the first quarter worth $579,000. Intech Investment Management LLC increased its stake in shares of Integer by 51.1% in the fourth quarter. Intech Investment Management LLC now owns 11,767 shares of the medical equipment provider’s stock worth $1,559,000 after purchasing an additional 3,980 shares in the last quarter. HighTower Advisors LLC increased its stake in shares of Integer by 1.4% in the fourth quarter. HighTower Advisors LLC now owns 12,207 shares of the medical equipment provider’s stock worth $1,618,000 after purchasing an additional 166 shares in the last quarter. Finally, Cibc World Markets Corp purchased a new stake in shares of Integer in the fourth quarter worth $413,000. 99.29% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages have recently issued reports on ITGR. Truist Financial set a $150.00 price objective on shares of Integer and gave the stock a “buy” rating in a research note on Friday, April 25th. Wall Street Zen raised shares of Integer from a “sell” rating to a “hold” rating in a research note on Monday, May 19th. Raymond James Financial increased their price objective on shares of Integer from $145.00 to $150.00 and gave the stock an “outperform” rating in a research note on Friday, April 25th. Benchmark cut their target price on shares of Integer from $150.00 to $140.00 and set a “buy” rating for the company in a research note on Friday, April 25th. Finally, Citigroup raised shares of Integer from a “hold” rating to a “strong-buy” rating and raised their target price for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Two research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $146.25.

Integer Stock Performance

ITGR opened at $112.51 on Friday. Integer Holdings Corporation has a fifty-two week low of $104.93 and a fifty-two week high of $146.36. The stock has a market capitalization of $3.93 billion, a price-to-earnings ratio of 53.32, a PEG ratio of 0.99 and a beta of 0.98. The company has a fifty day moving average of $119.65 and a 200 day moving average of $124.45. The company has a debt-to-equity ratio of 0.78, a quick ratio of 2.14 and a current ratio of 3.40.

Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Integer had a net margin of 4.38% and a return on equity of 11.95%. The business had revenue of $437.39 million during the quarter, compared to analysts’ expectations of $428.51 million. During the same period last year, the company posted $1.14 EPS. The business’s revenue was up 7.3% on a year-over-year basis. As a group, sell-side analysts forecast that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of Integer stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer directly owned 47,000 shares of the company’s stock, valued at $5,788,990. This trade represents a 87.82% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Martin C. Maxwell sold 8,720 shares of Integer stock in a transaction on Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the transaction, the director directly owned 22,170 shares of the company’s stock, valued at $2,672,815.20. The trade was a 28.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 362,434 shares of company stock valued at $44,577,115 in the last three months. Corporate insiders own 2.16% of the company’s stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.